Scholars@Duke
Journal cover image

Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials.

Publication ,  Journal Article
Peters, AE; Mentz, RJ; Greene, SJ
Published in: Eur Heart J Cardiovasc Pharmacother
June 2, 2023
Published version (DOI) Link to item

Duke Scholars

Robert John Mentz
Author Robert John Mentz Medicine, Cardiology
Stephen Greene
Author Stephen Greene Medicine, Cardiology

Published In

Eur Heart J Cardiovasc Pharmacother

DOI

10.1093/ehjcvp/pvad002

EISSN

2055-6845

Publication Date

June 2, 2023

Volume

9

Issue

4

Start / End Page

299 / 300

Location

England

Related Subject Headings

  • Humans
  • Heart Failure
  • Diuretics
  • 3214 Pharmacology and pharmaceutical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peters, A. E., Mentz, R. J., & Greene, S. J. (2023). Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials. Eur Heart J Cardiovasc Pharmacother, 9(4), 299–300. https://doi.org/10.1093/ehjcvp/pvad002
Peters, Anthony E., Robert J. Mentz, and Stephen J. Greene. “Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials.” Eur Heart J Cardiovasc Pharmacother 9, no. 4 (June 2, 2023): 299–300. https://doi.org/10.1093/ehjcvp/pvad002.
Peters AE, Mentz RJ, Greene SJ. Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):299–300.
Peters, Anthony E., et al. “Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials.” Eur Heart J Cardiovasc Pharmacother, vol. 9, no. 4, June 2023, pp. 299–300. Pubmed, doi:10.1093/ehjcvp/pvad002.
Peters AE, Mentz RJ, Greene SJ. Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):299–300.
Journal cover image

Published In

Eur Heart J Cardiovasc Pharmacother

DOI

10.1093/ehjcvp/pvad002

EISSN

2055-6845

Publication Date

June 2, 2023

Volume

9

Issue

4

Start / End Page

299 / 300

Location

England

Related Subject Headings

  • Humans
  • Heart Failure
  • Diuretics
  • 3214 Pharmacology and pharmaceutical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology